[144] Vital Farms, Inc. SEC Filing

Rhea-AI Filing Summary

Vital Farms, Inc. (Form 144) proposes the sale of 10,005 shares of common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $461,714.74 against total outstanding shares of 44,685,980. The proposed approximate sale date is 08/12/2025.

The 10,005 shares were acquired by the seller through restricted stock vesting under a registered plan on three dates: 03/10/2024 (5,662), 03/13/2024 (2,882), and 08/09/2024 (1,461). The filing reports "Nothing to Report" for securities sold in the past three months. Several administrative fields in the form (filer CIK/CCC, contact details, issuer address, date of notice, signature) are not provided in the supplied content.

Positive

• Transaction details are explicit: quantity, aggregate market value, broker, exchange, and planned sale date are provided
• Securities were acquired under a registered plan via restricted stock vesting, indicating compensation-related origin

Negative

• Key administrative fields are missing: filer CIK/CCC, submission contact details, issuer name/address, date of notice, and signature are not provided in the content
• Form lacks filer identity and contact transparency, limiting the ability to verify the seller from this filing alone

Insights

Securities Analyst

TL;DR: Routine Form 144 for a modest planned insider sale of 10,005 shares; disclosures are mostly complete on the transaction but key filer details are missing.

The filing documents a proposed sale of 10,005 Vital Farms common shares valued at $461,714.74 to occur on 08/12/2025 via Morgan Stanley Smith Barney on NASDAQ. The shares match three restricted stock vesting events in 2024 totaling 10,005 shares. The notice confirms no sales in the past three months. Material transactional details are explicit, but the absence of filer identifiers and contact information reduces transparency and makes it harder to confirm the seller's identity from this document alone.

Corporate Governance Expert

TL;DR: Transaction appears to be a routine disposition of vested restricted stock under a registered plan; incomplete administrative disclosure limits context.

The schedule of acquisition dates and quantities shows the shares were obtained through company-sponsored restricted stock vesting, suggesting standard compensation mechanics rather than an open-market acquisition. The filing includes broker and share-count details, but omitted issuer contact fields and signature/date entries reduce the filing's completeness for governance review. No past three-month disposals are reported, which is explicitly stated as "Nothing to Report."

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10005	461714.74	44685980	08/12/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/09/2024	Restricted stock vesting under a registered plan	Issuer			1461	08/09/2024	Not Applicable
Common	03/10/2024	Restricted stock vesting under a registered plan	Issuer			5662	03/10/2024	Not Applicable
Common	03/13/2024	Restricted stock vesting under a registered plan	Issuer			2882	03/13/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many shares is Vital Farms (VITL) proposing to sell?

The filing proposes the sale of 10,005 shares of common stock.

What is the aggregate market value of the proposed sale in the Form 144?

The aggregate market value is listed as $461,714.74.

When is the approximate date of sale and where will the shares be sold?

The approximate sale date is 08/12/2025, and the sale is planned on NASDAQ through Morgan Stanley Smith Barney LLC.

How were the 10,005 shares acquired?

They were acquired via restricted stock vesting under a registered plan on 03/10/2024 (5,662), 03/13/2024 (2,882), and 08/09/2024 (1,461).

Were any securities sold by the seller in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.

Does the Form 144 include the filer’s contact or signature information?

No. The supplied content does not include filer CIK/CCC, submission contact details, date of notice, or signature information.